Literature DB >> 52770

Is glucagon important in stable insulin-dependent diabetics?

A J Barnes, A Bloom, M F Crowley, J W Tuttlebee, S R Bloom, K G Alberti, P Smythe, D Turnell.   

Abstract

The role of glucagon has been evaluated in the everyday regulation of carbohydrate and lipid metabolism in insulin-dependent diabetic patients. Plasma concentrations of glucagon, growth hormone, cortisol, glucose, and free fatty acids and blood concentrations of glycerol, 3-hydroxybutyrate, acetoacetate, alanine, pyruvate, and lactate were measured in 38 fasting diabetic subjects deprived of their usual morning dose of insulin. The measurements were repeated in 25 of these patients after a further 3 hours of insulin deprivation and in 6 patients again at 6 hours. There was no correlation between the initial fasting levels of plasma-glucagon and those of the other biochemical measurements including glucose and ketone bodies. Furthermore, no correlation was found between changes in these measurements and in plasma-glucagon over a period of 3 or 6 hours. These findings suggest that glucagon is unlikely to play a role of primary importance in blood-glucose homoeostasis or ketone-body metabolism in ambulant insulin-dependent diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52770     DOI: 10.1016/s0140-6736(75)90722-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Relative insensitivity to glucagon of sterol synthesis in cultured rat aortic smooth muscle cells. Effect of dibutyryl cyclic AMP.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

2.  Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.

Authors:  P Felig; J Wahren; R Hendler
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

3.  Persistent metabolic abnormalities in diabetes in the absence of glucagon.

Authors:  A J Barnes; S R Bloom; K Mashiter; K G Alberti; P Smythe; D Turnell
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

4.  Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats.

Authors:  C L Brand; B Rolin; P N Jørgensen; I Svendsen; J S Kristensen; J J Holst
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

5.  Metabolic consequences of (regional) total pancreatectomy.

Authors:  C M Dresler; J G Fortner; K McDermott; D R Bajorunas
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  The nature of diabetes.

Authors:  A Bloom
Journal:  J R Soc Med       Date:  1978-03       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.